Developmental regulation of tau splicing is disrupted in stem cell derived neurons from frontotemporal dementia patients with the 10+16 splice-site mutation in MAPT

Tools

Sposito, Teresa and Preza, Elisavet and Mahoney, Colin J. and Setó-Salvia, Núria and Ryan, Natalie S. and Morris, Huw R. and Arber, Charles and Devine, Michael J. and Houlden, Henry and Warner, Thomas T. and Bushell, Trevor J. and Zagnoni, Michele and Kunath, Tilo and Livesey, Frederick J. and Fox, Nick C. and Rossor, Martin N. and Hardy, John and Wray, Selina (2015) Developmental regulation of tau splicing is disrupted in stem cell derived neurons from frontotemporal dementia patients with the 10+16 splice-site mutation in MAPT. Human Molecular Genetics, 24 (18). pp. 5260-5269. ISSN 0964-6906 (https://doi.org/10.1093/hmg/ddv246)

[thumbnail of Sposito-etal-HMG-2015-Developmental-regulation-of-tau-splicing-is-disrupted-in-stem-cell-cerived-neurons-from-frontotemporal-dementia-patients]
Preview
 Text. Filename: Sposito_etal_HMG_2015_Developmental_regulation_of_tau_splicing_is_disrupted_in_stem_cell_cerived_neurons_from_frontotemporal_dementia_patients.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (688kB)| Preview

Abstract

The alternative splicing of the tau gene, MAPT, generates six protein isoforms in the adult human CNS. Tau splicing is developmentally regulated and dysregulated in disease. Mutations in MAPT that alter tau splicing cause frontotemporal dementia (FTD) with tau pathology, providing evidence for a causal link between altered tau splicing and disease. The use of induced pluripotent stem cell (iPSC) derived neurons has revolutionized the way we model neurological disease in vitro. However, as most tau mutations are located within or around the alternatively spliced exon 10, it is important that iPSC-neurons splice tau appropriately in order to be used as disease models. To address this issue, we analysed the expression, and splicing of tau in iPSC-derived cortical neurons from control patients and FTD patients with the 10+16 intronic mutation in MAPT. We show that control neurons only express the fetal tau isoform (0N3R), even at extended time points of 100 days in vitro. Neurons from FTD patients with the 10+16 mutation in MAPT express both 0N3R and 0N4R tau isoforms, demonstrating that this mutation overrides the developmental regulation of exon 10 inclusion in our in vitro model. Further, at extended time-points of 365 days in vitro, we observe a switch in tau splicing to include six tau isoforms as seen the adult human CNS. Our results demonstrate the importance of neuronal maturity for use in in vitro modeling and provide a system that will be important for understanding the functional consequences of altered tau splicing.

ORCID iDs

Sposito, Teresa, Preza, Elisavet, Mahoney, Colin J., Setó-Salvia, Núria, Ryan, Natalie S., Morris, Huw R., Arber, Charles, Devine, Michael J., Houlden, Henry, Warner, Thomas T., Bushell, Trevor J. ORCID logoORCID: https://orcid.org/0000-0003-4145-9670, Zagnoni, Michele ORCID logoORCID: https://orcid.org/0000-0003-3198-9491, Kunath, Tilo, Livesey, Frederick J., Fox, Nick C., Rossor, Martin N., Hardy, John and Wray, Selina;
CORE (COnnecting REpositories)